Arrowhead Pharmaceuticals, Inc.
ARWR
$55.05
$0.040.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -0.30% | 2.15% | -18.00% | 98.85% | -18.69% |
| Total Receivables | 3,107.37% | -29.64% | 310.11% | -5.40% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 46.83% | -53.85% | -0.32% | 153.78% | -1.79% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 60.58% | 0.36% | 11.49% | 75.84% | -7.53% |
| Total Current Assets | 23.54% | 0.39% | -16.59% | 98.97% | -17.96% |
|
|
|||||
| Total Current Assets | 23.54% | 0.39% | -16.59% | 98.97% | -17.96% |
| Net Property, Plant & Equipment | -1.05% | 0.32% | -0.98% | -0.62% | 0.15% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -6.19% | -5.83% | -5.51% | -5.24% | -4.96% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.58% | 2.66% | 3.13% | -57.44% | -31.21% |
| Total Assets | 15.80% | 0.34% | -12.26% | 55.22% | -11.06% |
|
|
|||||
| Total Accounts Payable | 86.36% | -46.52% | 231.16% | -30.97% | 26.95% |
| Total Accrued Expenses | -3.59% | 14.88% | -11.55% | 39.06% | -15.72% |
| Short-term Debt | 0.97% | 45.07% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.51% | 0.59% | -34.51% | 776.99% | 29.06% |
| Total Finance Division Other Current Liabilities | 582.81% | 1.64% | -46.45% | 1,362.31% | -35.02% |
| Total Other Current Liabilities | 582.81% | 1.64% | -46.45% | 1,362.31% | -35.02% |
| Total Current Liabilities | 77.72% | 0.49% | -11.79% | 135.22% | -9.12% |
|
|
|||||
| Total Current Liabilities | 77.72% | 0.49% | -11.79% | 135.22% | -9.12% |
| Long-Term Debt | -7.59% | 3.87% | -0.11% | -25.63% | 2.73% |
| Short-term Debt | 0.97% | 45.07% | -- | -- | -- |
| Capital Leases | -1.90% | -1.49% | -1.71% | -1.62% | -1.56% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 18.10% | 2.45% | -3.20% | -7.14% | 0.94% |
|
|
|||||
| Common Stock & APIC | 3.33% | 0.92% | 0.63% | 14.08% | 2.26% |
| Retained Earnings | 1.89% | -1.48% | -12.27% | 20.60% | -10.65% |
| Treasury Stock & Other | 0.55% | -972.69% | 22.03% | 6.12% | -12.91% |
| Total Common Equity | 21.97% | -10.77% | -23.56% | 1,199.36% | -71.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 21.97% | -10.77% | -23.56% | 1,199.36% | -71.64% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -115.32% | 1,590.39% | -377.32% | -74.07% | -37.96% |
| Total Equity | 11.78% | -3.15% | -24.03% | 1,120.20% | -70.65% |
|
|
|||||